A Trial of Digoxin Before Second-Trimester Abortion

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of our study is to determine the optimum route for the injection of digoxin prior to second-trimester surgical abortion.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: White, Katharine O'Connell, M.D., M.P.H.
• Collaborator: Society of Family Planning
• Treatments: Digoxin

Criteria

Inclusion Criteria:

• at least 18 years old

• English or Spanish speaking

• be able to give informed consent

• documented fetal cardiac activity.

Exclusion Criteria:

• significant medical illness or cardiovascular disease

• current use of cardiac or antihypertensive medications

• cardiac arrhythmia on preoperative EKG

• multiple gestation

• morbid obesity (BMI greater than 40)

• known digoxin allergy